UNILIFE CORPORATION SHAREHOLDER ALERT: Levi & Korsinsky,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
UNILIFE CORPORATION SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Unilife Corporation and Its Board of Directors and a Lead Plaintiff Deadline of December 31, 2013 -- UNIS

NEW YORK, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Middle District of Pennsylvania on behalf of investors who purchased Unilife Corporation ("Unilife" or the "Company") (Nasdaq: UNIS ) common stock between July 13, 2011 and September 9, 2013.

For more information, click here: http://zlk.9nl.com/unilife-unis/ .

The complaint alleges that the Company made false and/or misleading statements and/or failed to disclose that: (a) the Company's Unilife syringes failed to comply with the Food and Drug Administration's ("FDA") validation processes; (b) the Company's Quality Management System failed to comply with FDA regulations; and (c) the Company purposefully increased its purchases of Unilife component parts to make suppliers believe Unilife was producing at increased volumes despite a lack of customer demand or manufacturing capacity to support such purchases.

On August 30, 2013, a former Unilife employee filed a "whistleblower" lawsuit alleging that his employment was terminated after he reported regulatory violations to the appropriate authorities. Then on September 3, 2013, Forbes published an article that stated the Company's main manufacturing facility was operating at 3% capacity; upon this news shares of Unilife fell more than 14 percent.

If you suffered a loss in Unilife you have until December 31, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/unilife-unis/ .

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Brixton Metals Expands Thorn Project with New Mineral Claims

Updated Category News Views 198

Brixton Metals Expands Thorn Project with New Mineral Claims Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) has expanded its footprint at the Thorn Project, securing a 100% interest in mineral claims covering 6,446 hectares. These claims, which were previously outside Brixton’s control, sit northwest of the well-known Golden Bear Mine and add ground the company...

Continue Reading
Nutex Health Awaits Q2 Results Amid Regulatory Hurdles

Updated Category News Views 20

Diving headfirst into the grumbles of this healthcare whirlwind we call Nutex Health. They've set the table to drop their Q2 financials on August 6, right after the bell, followed by a chat with investors the next morning. We're talking bumper-to-bumper business news here, and everyone with a slice in NASDAQ: NUTX better have their ears pricked. Nutex Health: A Mixed Bag...

Continue Reading
Arvore Partners LP Announces Impressive October Distribution

Updated Category News Views 183

Arvore Partners LP Declares Monthly Distribution for October Arvore Partners LP is thrilled to share details about the declaration of its monthly distribution for October. This distribution amounts to $687,365, which translates to an impressive 9.06% annualized yield for its unitholders, marking a 7% increase from the previous month. This consistent growth highlights...

Continue Reading
Key Insights on Marathon Petroleum's Upcoming Earnings Call

Updated Category News Views 101

An Overview of Marathon Petroleum's Earnings Expectations Marathon Petroleum (NYSE: MPC) is gearing up for its quarterly earnings announcement. Investors should prepare for necessary insights leading up to the release of this important announcement. Analysts predict a solid earnings per share (EPS) of $3.23 for the upcoming quarter. While it’s crucial for the company to...

Continue Reading
Revolutionizing Male Infertility Research with PacBio's Revio

Updated Category News Views 80

Transforming Male Infertility Research with PacBio's Revio MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading name in sequencing solutions, is launching an exciting collaboration with the University Hospital of Münster. This partnership is set to leverage long-read whole genome sequencing to significantly advance research in male infertility and rare diseases....

Continue Reading